Vanderbilt University Institute of Imaging Science

Blocking tumor ‘signals’ and ‘fuel’

Combining two drugs reduced colorectal cancer cell growth in vitro and in an animal model, suggesting the combination may be a promising treatment for patients.

Imaging breast cancer cell size

A noninvasive MRI approach assesses breast tumor cell size and could be a useful way to evaluate early response to neoadjuvant therapy.

Imaging nerve regeneration

Diffusion MRI may provide a noninvasive approach to assess nerve regeneration and distinguish successful from unsuccessful repairs earlier.

Gore named to committee on worker health overseas

John Gore, PhD, has been appointed to a National Academies of Sciences, Engineering and Medicine standing committee to advise the Department of State on unexplained health effects on U.S. government employees and their families at overseas embassies.

Charles Manning, PhD, and colleagues are working to improve the effectiveness of immunotherapies earlier in treatment.

Project seeks new way to assess immunotherapy effectiveness

GE Healthcare has awarded researchers in the Vanderbilt University Institute of Imaging Science $2.5 million in funding to develop PET tracer that will determine the effectiveness of immunotherapy in patients early in their treatment course.

Researchers developing a focused ultrasound neuromodulation device for treating chronic pain include, from left, Charles Caskey, PhD, William Grissom, PhD, and Li Min Chen, MD, PhD.

Device studied as non-addictive option for chronic pain

Vanderbilt researchers are developing a focused ultrasound neuromodulation device as a non-invasive and non-addictive method for treating chronic pain.

1 2 3 4 5